SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-054352
Filing Date
2014-02-14
Accepted
2014-02-14 14:44:33
Documents
1
Group Members
ENRICO PETRILLOEXCEL MEDICAL VENTURES, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d675298dsc13g.htm SC 13G 137009
  Complete submission text file 0001193125-14-054352.txt   138675
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87366 | Film No.: 14615031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTONE STREET SUITE 1585 BOSTON MA 02199
Business Address 800 BOYLSTONE STREET SUITE 1585 BOSTON MA 02199 617-450-9800
EXCEL MEDICAL FUND LP (Filed by) CIK: 0001428044 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G